About
Marion McCourt joined Regeneron in 2018 and serves as Senior Vice President and Head of the Commercial organization. Prior to joining Regeneron, Marion was at Axovant, a clinical-stage biopharmaceutical company, where she was President and Chief Operating Officer. She served as Chief Operating Officer of Medivation until it was acquired by Pfizer in 2016, and before that held commercial leadership roles at Amgen, including Vice President in U.S. Commercial Operations and Vice President and General Manager responsible for the company’s bone health and primary care business unit. Marion began her career—and spent 12 years—at AstraZeneca, ultimately becoming Chief Operating Officer for AstraZeneca U.S. She received her BS from Lafayette College.
Investment Focus
- Location
- US
Contact Information
Find more investors like Marion
Search Investors